Get the tools used by (smart)2 investors.
SP500 -1.5%DOW -0.8%FTSE 100 -3.4%NIKKEI -3.5%OIL -4.0%GOLD 0.5%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Debt / Common Equity for Zimmer Biomet Holdings Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

ZBH: Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, suc...

102.79 USD
Price
– USD
Fair Value
–
Upside
97.69 - 129.50
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Zimmer Biomet Holdings Inc's Debt / Common Equity:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 202440.0%60.0%80.0%100.0%120.0%140.0%
Performance Summary
  • Zimmer Biomet's debt / equity last quarter was 53.1%
  • Zimmer Biomet's debt / equity for fiscal years ending December 2020 to 2024 averaged 56.3%.
  • Zimmer Biomet's operated at median debt / equity of 53.1% from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Zimmer Biomet's debt / equity peaked in December 2020 at 69.7%.
  • Zimmer Biomet's debt / equity hit its 5-year low in December 2023 of 49.7%.
  • Zimmer Biomet's debt / equity decreased in 2021 (57.8%, -17.1%), 2022 (51.1%, -11.6%), and 2023 (49.7%, -2.6%) and increased in 2020 (69.7%, +1.6%) and 2024 (53.1%, +6.8%).

Benchmarks

Metric Usage: Debt / Equity

Hide this widget
debt_to_equity
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Debt / Common Equity in the risk category include:

  • James Montier's C-score - C-Score developed by James Montier is a score between 0-6 that attempts to identify companies that may be manipulating earnings or "cooking the books".
  • Net Debt / EBITDA - A ratio that is calculated as net debt divided by EBITDA.
  • Sloan Ratio - A formula developed by Richard Sloan in 1996 that measures the degree of accruals versus reported earnings.
  • Cash Ratio - A strict ratio used to assess a company's short-term liquidity.
View Full List

Search for metric or datapoint

Debt / Equity

A ratio that measures the level of the debt relative to the book value of common equity.

Definition of Debt / Common Equity

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-381.5%-81.5%218.5%622.4%2006001,000

The chart above depicts the distribution of debt / common equity for companies operating in the Healthcare sector in the Developed economic region. Over 2,450 companies were considered in this analysis, and 2,361 had meaningful values. The average debt / common equity of companies in the sector is 26.5% with a standard deviation of 100.6%.

Zimmer Biomet Holdings Inc's Debt / Common Equity of 53.1% ranks in the 75.9% percentile for the sector. The following table provides additional summary stats:

Debt / Common Equity In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,459
Included Constituents2,361
Min-382.2%
Max618.8%
Median7.1%
Mean26.5%
Standard Deviation100.6%

You can find companies with similar debt / common equity using this stock screener.

All rights reserved. Terms Of Use